Saad Usmani, MD, discusses iberdomide approval in relapsed multiple myeloma
Dr. Saad Usmani, chief of the Myeloma Service at Memorial Sloan Kettering Cancer Center, discusses the FDA approval of iberdomide plus dexamethasone in
Multiple Myeloma News
SOHO 2026
Trending now
Meetings / Conferences
MDS News
SOHO 2026
Valeria Santini, MD, on earlier intervention, improving survival in MDS
In this video, Dr. Valeria Santini provides an overview of the SOHO 2026 MDS session. She covers novels agents and future research needs
MDS News
SOHO 2026
Video Interviews
What stood out at SOHO 2026? Dr. Garcia-Manero shares his highlights from the meeting
Beyond the scientific and educational programming, Dr. Garcia-Manero reflected on the opportunity to recognize leaders in the field. He described it as a
FOCUS on DREAMM
Roundtable Discussions
Video Interviews
‘No hesitation holding therapy’ — managing ocular adverse events in myeloma
“We recommend artificial tears,” Dr. Dimopoulos said, adding that his team may also hold the drug when needed and provide patients with practical
FOCUS on DREAMM
Trending now
Roundtable Discussions
Video Interviews
‘It’s a beautiful drug development story.’ Looking back at 8 years of belantamab mafodotin
“It’s a beautiful drug development story. It only took eight years, but now it’s available to you,” Dr. Nooka said in the video.
FOCUS on DREAMM
Roundtable Discussions
Video Interviews
What are the DREAMM-7 and DREAMM-8 trials?
The roundtable panelists provide an historical overview of the DREAMM-7 and DREAMM-8 trials in multiple myeloma.
Acute Lymphoblastic Leukemia News
SOHO 2026
Meetings / Conferences
Selina Luger, MD, weighs the promise and challenges of modern ALL care
I’ve seen SOHO evolve over the dozen or so years since it was established. SOHO plays a unique role in bringing cutting-edge advances
Leukemia
Lymphoma
Multiple Myeloma
Myelodysplastic Syndromes
Myeloproliferative Neoplasms
Primary Myelofibrosis
Video Interviews
Society Updates
Register for SOHO Breakthroughs in Blood Cancers
SOHO Breakthroughs in Blood Cancers, a one-day virtual meeting, will be held on November 12, 2026.
MPN News
SOHO 2026
Trending now
Video Interviews
Initial RESTORE-PV results show reduced phlebotomy burden with DISC-3405
Naveen Pemmaraju, MD, of the University of Texas MD Anderson Cancer Center, discusses initial results from the phase 2 RESTORE-PV trial evaluating DISC-3405
MDS News
SOHO 2026
Trending now
Society Updates
Member Spotlight: Valeria Santini, MD
The Board of Directors and the Steering Committee of the Society of Hematologic Oncology (SOHO) are pleased to announce that Valeria Santini, MD,